COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 132: Articles 1311-1320  | Next

Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage
Powers, C., Williams, B., Kreher, A., Gao, F., West, B., Chupp, D., Allen, R.
10.1101/2024.11.11.623127 — Posted: 2024-11-13
SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness.
Zhou, Y., Ahearn, Y. P., Lokugamage, K. G., Alvarado, R. E., Estes, L. K., Meyers, W. M., McLeland, A. M., Morgan, A. L., Murray, J. T., Walker, D. H., Johnson, B. A., Routh, A. L., Menachery, V. D.
10.1101/2024.11.11.622995 — Posted: 2024-11-13
COMPARATIVE CHARACTERISTICS OF THE ACCUMULATION OF DIFFERENT VARIANTS OF THE SARS-COV-2 VIRUS (WUHAN, DELTA, OMICRON) IN THE ORGANS OF MODEL ANIMALS
Chernov, A., Kazakov, V., Gogleva, I., Savenko, S., Schukina, V., Loginova, S., Smirnov, I., Borisevich, S., Telegin, G., Belogurov, A.
10.1101/2024.11.12.623177 — Posted: 2024-11-13
Pivoting Back to the In-Person Capstone Biochemistry Lab: Lessons Learned from the COVID-19 Online Modality to Improve the Course-based Undergraduate Research Experience
Rascon, A. A.
10.1101/2024.11.11.623056 — Posted: 2024-11-13
Genomic characterization of a persistent, azole-resistant C. parapsilosis strain responsible for a hospital outbreak during the first COVID-19 wave
Vumbaca, M., Batisti Biffignandi, G., Cavanna, C., Belllinzona, G., Corbella, M., Cambieri, P., Rhodes, J., Corander, J., Baldanti, F., Sassera, D.
10.1101/2024.11.11.622614 — Posted: 2024-11-12
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Keeling, M. J., Hill, E. M., Petrou, S., Bich Tran, P., Png, M. E., Staniszewska, S., Clark, C., Hassel, K., Stowe, J., Andrews, N.
10.1101/2024.11.08.24316972 — Posted: 2024-11-12
Implementation and results of active vaccine safety monitoring during the COVID-19 pandemic in the UK
Wong, J., Donegan, K., Harrison, K., Jan, T., Cave, A., Tregunno, P.
10.1101/2024.11.06.24316782 — Posted: 2024-11-12
Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022).
Parry, R. H., Shang, Y. H., Sng, J. D. J., McMillan, C. L. D., Modhiran, N., Amarilla, A. A., Isaacs, A., Liang, B., Muller, D. A., Rawle, D. J., Suhrbier, A., Anderson, S., Kelly, S., Watterson, D., Burr, L., Khromykh, A.
10.1101/2024.11.11.623100 — Posted: 2024-11-12
The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation
Swanson, K., Wu, W., Bulaong, N. L., Pak, J. E., Zou, J.
10.1101/2024.11.11.623004 — Posted: 2024-11-12
Wastewater sequencing from a rural community enables identification of widespread adaptive mutations in a SARS-CoV-2 Alpha variant
Conway, M. J., Novay, M. P., Pusch, C. M., Ward, A. S., Abel, J. D., Williams, M. R., Uzarski, R. L., Alm, E. W.
10.1101/2024.11.11.24316360 — Posted: 2024-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).